[ Price : $8.95]
FDA joins the United States Pharmacopeia and the Association for Accessible Medicines next month for a public workshop focused on ...[ Price : $8.95]
Orrick attorneys say discussions at an FDA Digital Health Advisory Committee meeting indicate the agency intends to adopt oversigh...[ Price : $8.95]
FDA approves Promegas OncoMate MSI Dx Analysis System as a companion diagnostic for identifying endometrial carcinoma patients who...[ Price : $8.95]
FDA introduces a new regulatory framework the plausible mechanism pathway designed to speed approval of highly personalized ther...[ Price : $8.95]
FDA warns New Zealands Miers Laboratories about repeat CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
Neurocrine Biosciences reports that its Phase 2 study of NBI-1070770, an investigational NMDA receptor modulator for major depress...[ Price : $8.95]
Alston & Bird attorneys urge medical device companies to move quickly to prepare to implement FDAs new Quality Management System R...[ Price : $8.95]
enGene says Phase 2 data showed that its gene therapy detalimogene voraplasmid produced a 62% complete response rate at six months...